Software - Application
Compare Stocks
4 / 10Stock Comparison
SURG vs GSAT vs SPOK vs IRDM
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Medical - Healthcare Information Services
Telecommunications Services
SURG vs GSAT vs SPOK vs IRDM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Telecommunications Services | Medical - Healthcare Information Services | Telecommunications Services |
| Market Cap | $11M | $10.33B | $225M | $4.25B |
| Revenue (TTM) | $50M | $262M | $103M | $876M |
| Net Income (TTM) | $-42M | $-50M | $11M | $106M |
| Gross Margin | -38.6% | 57.2% | 91.4% | 62.5% |
| Operating Margin | -78.8% | 1.4% | 13.2% | 25.8% |
| Forward P/E | — | — | 16.4x | 36.1x |
| Total Debt | $5M | $542M | $7M | $1.76B |
| Cash & Equiv. | $12M | $391M | $25M | $97M |
SURG vs GSAT vs SPOK vs IRDM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SurgePays, Inc. (SURG) | 100 | 3.6 | -96.4% |
| Globalstar, Inc. (GSAT) | 100 | 1826.9 | +1726.9% |
| Spok Holdings, Inc. (SPOK) | 100 | 105.5 | +5.5% |
| Iridium Communicati… (IRDM) | 100 | 174.7 | +74.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SURG vs GSAT vs SPOK vs IRDM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SURG lags the leaders in this set but could rank higher in a more targeted comparison.
GSAT is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 11.9%, EPS growth -195.0%, 3Y rev CAGR 26.3%
- 201.8% 10Y total return vs IRDM's 412.1%
- 11.9% revenue growth vs SURG's -55.6%
- +305.2% vs SURG's -78.9%
SPOK carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 5 yrs, beta 0.42, yield 11.9%
- Lower volatility, beta 0.42, Low D/E 4.7%, current ratio 1.18x
- Beta 0.42, yield 11.9%, current ratio 1.18x
- Lower P/E (16.4x vs 36.1x)
IRDM is the clearest fit if your priority is quality.
- 12.1% margin vs SURG's -83.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% revenue growth vs SURG's -55.6% | |
| Value | Lower P/E (16.4x vs 36.1x) | |
| Quality / Margins | 12.1% margin vs SURG's -83.4% | |
| Stability / Safety | Beta 0.42 vs GSAT's 2.08, lower leverage | |
| Dividends | 11.9% yield, 5-year raise streak, vs GSAT's 0.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | +305.2% vs SURG's -78.9% | |
| Efficiency (ROA) | 5.2% ROA vs SURG's -242.4%, ROIC 11.3% vs -229.7% |
SURG vs GSAT vs SPOK vs IRDM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SURG vs GSAT vs SPOK vs IRDM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SPOK leads in 3 of 6 categories
GSAT leads 1 • SURG leads 0 • IRDM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SURG and IRDM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IRDM is the larger business by revenue, generating $876M annually — 17.4x SURG's $50M. IRDM is the more profitable business, keeping 12.1% of every revenue dollar as net income compared to SURG's -83.4%. On growth, SURG holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $50M | $262M | $103M | $876M |
| EBITDAEarnings before interest/tax | -$39M | $93M | $17M | $439M |
| Net IncomeAfter-tax profit | -$42M | -$50M | $11M | $106M |
| Free Cash FlowCash after capex | -$26M | $151M | $26M | $305M |
| Gross MarginGross profit ÷ Revenue | -38.6% | +57.2% | +91.4% | +62.5% |
| Operating MarginEBIT ÷ Revenue | -78.8% | +1.4% | +13.2% | +25.8% |
| Net MarginNet income ÷ Revenue | -83.4% | -19.0% | +10.3% | +12.1% |
| FCF MarginFCF ÷ Revenue | -50.9% | +57.6% | +24.7% | +34.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +2.1% | -100.0% | +1.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +47.2% | -121.9% | -64.0% | -25.9% |
Valuation Metrics
SPOK leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 14.4x trailing earnings, SPOK trades at a 62% valuation discount to IRDM's 37.9x P/E. On an enterprise value basis, SPOK's 8.9x EV/EBITDA is more attractive than GSAT's 119.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $11M | $10.3B | $225M | $4.2B |
| Enterprise ValueMkt cap + debt − cash | $4M | $10.5B | $206M | $5.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.23x | -138.10x | 14.44x | 37.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 16.41x | 36.13x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 119.09x | 8.91x | 13.25x |
| Price / SalesMarket cap ÷ Revenue | 0.18x | 41.28x | 1.61x | 4.87x |
| Price / BookPrice ÷ Book value/share | 0.70x | 28.58x | 1.56x | 9.37x |
| Price / FCFMarket cap ÷ FCF | — | 57.85x | 8.91x | 14.17x |
Profitability & Efficiency
SPOK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
IRDM delivers a 22.8% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $-10 for SURG. SPOK carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRDM's 3.81x. On the Piotroski fundamental quality scale (0–9), IRDM scores 8/9 vs SURG's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.1% | -13.7% | +7.3% | +22.8% |
| ROA (TTM)Return on assets | -2.4% | -2.3% | +5.2% | +4.1% |
| ROICReturn on invested capital | -2.3% | -0.1% | +11.3% | +8.0% |
| ROCEReturn on capital employed | -177.3% | -0.1% | +12.1% | +9.6% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.30x | 1.51x | 0.05x | 3.81x |
| Net DebtTotal debt minus cash | -$7M | $151M | -$18M | $1.7B |
| Cash & Equiv.Liquid assets | $12M | $391M | $25M | $97M |
| Total DebtShort + long-term debt | $5M | $542M | $7M | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | -40.65x | -0.07x | — | 2.67x |
Total Returns (Dividends Reinvested)
GSAT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GSAT five years ago would be worth $49,382 today (with dividends reinvested), compared to $715 for SURG. Over the past 12 months, GSAT leads with a +305.2% total return vs SURG's -78.9%. The 3-year compound annual growth rate (CAGR) favors GSAT at 80.1% vs SURG's -49.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -67.4% | +27.3% | -14.3% | +127.1% |
| 1-Year ReturnPast 12 months | -78.9% | +305.2% | -26.7% | +55.0% |
| 3-Year ReturnCumulative with dividends | -86.9% | +484.1% | +13.4% | -33.9% |
| 5-Year ReturnCumulative with dividends | -92.8% | +393.8% | +61.9% | +10.7% |
| 10-Year ReturnCumulative with dividends | -99.1% | +201.8% | +13.3% | +412.1% |
| CAGR (3Y)Annualised 3-year return | -49.3% | +80.1% | +4.3% | -12.9% |
Risk & Volatility
Evenly matched — GSAT and SPOK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPOK is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than GSAT's 2.08 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GSAT currently trades 98.3% from its 52-week high vs SURG's 16.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 2.08x | 0.42x | 1.05x |
| 52-Week HighHighest price in past year | $3.45 | $82.85 | $19.31 | $44.36 |
| 52-Week LowLowest price in past year | $0.46 | $17.24 | $9.96 | $15.65 |
| % of 52W HighCurrent price vs 52-week peak | +16.2% | +98.3% | +56.1% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 39.9 | 66.4 | 36.7 | 63.3 |
| Avg Volume (50D)Average daily shares traded | 378K | 1.5M | 185K | 2.3M |
Analyst Outlook
SPOK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GSAT as "Hold", SPOK as "Hold", IRDM as "Buy". Consensus price targets imply 38.5% upside for SPOK (target: $15) vs -19.0% for GSAT (target: $66). For income investors, SPOK offers the higher dividend yield at 11.95% vs GSAT's 0.10%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $66.00 | $15.00 | $35.50 |
| # AnalystsCovering analysts | — | 5 | 1 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +0.1% | +11.9% | +1.5% |
| Dividend StreakConsecutive years of raises | — | 2 | 5 | 3 |
| Dividend / ShareAnnual DPS | — | $0.08 | $1.29 | $0.58 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% | +1.3% | +4.4% |
SPOK leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). GSAT leads in 1 (Total Returns). 2 tied.
SURG vs GSAT vs SPOK vs IRDM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SURG or GSAT or SPOK or IRDM a better buy right now?
For growth investors, Globalstar, Inc.
(GSAT) is the stronger pick with 11. 9% revenue growth year-over-year, versus -55. 6% for SurgePays, Inc. (SURG). Spok Holdings, Inc. (SPOK) offers the better valuation at 14. 4x trailing P/E (16. 4x forward), making it the more compelling value choice. Analysts rate Iridium Communications Inc. (IRDM) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SURG or GSAT or SPOK or IRDM?
On trailing P/E, Spok Holdings, Inc.
(SPOK) is the cheapest at 14. 4x versus Iridium Communications Inc. at 37. 9x. On forward P/E, Spok Holdings, Inc. is actually cheaper at 16. 4x.
03Which is the better long-term investment — SURG or GSAT or SPOK or IRDM?
Over the past 5 years, Globalstar, Inc.
(GSAT) delivered a total return of +393. 8%, compared to -92. 8% for SurgePays, Inc. (SURG). Over 10 years, the gap is even starker: IRDM returned +412. 1% versus SURG's -99. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SURG or GSAT or SPOK or IRDM?
By beta (market sensitivity over 5 years), Spok Holdings, Inc.
(SPOK) is the lower-risk stock at 0. 42β versus Globalstar, Inc. 's 2. 08β — meaning GSAT is approximately 396% more volatile than SPOK relative to the S&P 500. On balance sheet safety, Spok Holdings, Inc. (SPOK) carries a lower debt/equity ratio of 5% versus 4% for Iridium Communications Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SURG or GSAT or SPOK or IRDM?
By revenue growth (latest reported year), Globalstar, Inc.
(GSAT) is pulling ahead at 11. 9% versus -55. 6% for SurgePays, Inc. (SURG). On earnings-per-share growth, the picture is similar: Iridium Communications Inc. grew EPS 12. 8% year-over-year, compared to -273. 2% for SurgePays, Inc.. Over a 3-year CAGR, GSAT leads at 26. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SURG or GSAT or SPOK or IRDM?
Iridium Communications Inc.
(IRDM) is the more profitable company, earning 13. 1% net margin versus -75. 1% for SurgePays, Inc. — meaning it keeps 13. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRDM leads at 27. 1% versus -68. 6% for SURG. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SURG or GSAT or SPOK or IRDM more undervalued right now?
On forward earnings alone, Spok Holdings, Inc.
(SPOK) trades at 16. 4x forward P/E versus 36. 1x for Iridium Communications Inc. — 19. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SPOK: 38. 5% to $15. 00.
08Which pays a better dividend — SURG or GSAT or SPOK or IRDM?
In this comparison, SPOK (11.
9% yield), IRDM (1. 5% yield), GSAT (0. 1% yield) pay a dividend. SURG does not pay a meaningful dividend and should not be held primarily for income.
09Is SURG or GSAT or SPOK or IRDM better for a retirement portfolio?
For long-horizon retirement investors, Spok Holdings, Inc.
(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 11. 9% yield). Globalstar, Inc. (GSAT) carries a higher beta of 2. 08 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SPOK: +13. 3%, GSAT: +201. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SURG and GSAT and SPOK and IRDM?
These companies operate in different sectors (SURG (Technology) and GSAT (Communication Services) and SPOK (Healthcare) and IRDM (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SURG is a small-cap quality compounder stock; GSAT is a mid-cap quality compounder stock; SPOK is a small-cap deep-value stock; IRDM is a small-cap quality compounder stock. SPOK, IRDM pay a dividend while SURG, GSAT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.